Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ambroxol hydrochloride for lower respiratory tract infection with viscous sputum
CTR20180971Phase 3Completed
- Sponsor
- Roxin Pharmaceutical
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by Roxin Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20180971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180971.